Moreover, they noticed that NGAL(+)/SCr(-) tests identified approximately 40% more acute kidney injury cases than SCr(+) alone and that these patients were at greater risk of longer intensive care unit and hospital stay, renal replacement therapy and death compared with control subjects. This evidence concerns the gene LCN2 and acute kidney injury.